Evidence map›Paper›PMID 41480649›Full record

ArticleEpidemiology and infection2026

Camilo Suarez-Ariza, Zipporah Gitau, Maria Arango-Uribe, Mariana Herrera, Camila Oda, Angela Copete, Rotem Keynan, Ameeta E Singh, Stuart Skinner, Cara Spence and 11 more

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology and infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Camilo Suarez-ArizaDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba Faculty of Health Sciences, Canada.
Zipporah GitauDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba Faculty of Health Sciences, Canada.
Maria Arango-UribeDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba Faculty of Health Sciences, Canada.
Mariana HerreraDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba Faculty of Health Sciences, Canada.
Camila OdaDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba Faculty of Health Sciences, Canada.
Angela CopeteDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba Faculty of Health Sciences, Canada.
Rotem KeynanDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba Faculty of Health Sciences, Canada.
Ameeta E SinghDepartment of Medicine, University of Alberta, Canada.
Stuart SkinnerDepartment of Medicine, University of Saskatchewan, Canada.
Cara SpenceWellness Wheel Clinic, Canada.
Lauren J MacKenzieDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba Faculty of Health Sciences, Canada.
Ken KasperDepartment of Internal Medicine, University of Manitoba, Canada.
Laurie IrelandManitoba HIV Program, Canada.
Irene MartinStreptococcus and STI Section, National Microbiology Laboratory, Canada.
Jared BullardDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba Faculty of Health Sciences, Canada.
David AlexanderDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba Faculty of Health Sciences, Canada.
Diana MarinSchool of Medicine, Universidad Pontificia Bolivariana, Colombia.
Lucelly LopezSchool of Medicine, Universidad Pontificia Bolivariana, Colombia.
Margareth Haworth-BrockmanDepartment of Community Health Sciences, University of Manitoba, Canada.
Yoav KeynanDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba Faculty of Health Sciences, Canada.
Zulma Vanessa RuedaDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba Faculty of Health Sciences, Canada.ORCID 0000-0001-6342-1812

Funding

Canada Research Chairs 950-232963CIHR ED6-190717;OS3-190782;OS3-190782,PJH-185724,PJT-195685,Research Excellence, Diversity, and IndependenceGlobal Affairs Canada Canadian International Development Scholarships 20
6 · The paper itself

Abstract

We aimed to describe the evolution of gonorrhea infection and its antimicrobial resistance patterns in the Prairie provinces compared to Canada between 1980 and 2022. Data was collected from publicly available sexually transmitted infection reports in Canada, Alberta, Saskatchewan, and Manitoba. We extracted the number and rates of gonorrhea cases; percentage of cases by sex, age, ethnicity, sexual orientation; and data on cases diagnosed by culture and antimicrobial resistance. Descriptive statistics and age-period-cohort effect analysis were used. Gonorrhea cases in Canada rose from 32.4 per 100 000 in 1992 to 92.3 in 2022. In 2020, 36.9% of gonorrhea cases in Canada were females, compared to 42.8% in Alberta, 55.3% in Saskatchewan and 56% in Manitoba. People aged ≥30 years represented 22.5% of cases in 1980, and 54.1% in 2022. By 2022, the proportion of Canadian cases detected by culture declined to less than 10%, and azithromycin resistance of

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialGonorrheaNeisseria gonorrhoeaeAdolescentAdultAgedAlbertaCanadaChildFemaleHumansMaleManitobaMiddle AgedSaskatchewanAnti-Bacterial AgentsAlbertaantimicrobial resistanceCanadaecological studygonorrheaManitobaNeisseria gonorrhoeaeSaskatchewansexually transmitted infections

Identifiers

PMID41480649
PMCPMC12813727

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.